Season 2, Episode 4 — The Word That Covered the Spread

Send us Fan MailA hospital system in Indianapolis paid the federal government $345 million last year to settle systematic kickback allegations. The day after the settlement, that hospital continued to buy pharmaceuticals at 25 to 50 percent below wholesale through a federal program called 340B. It continued to bill Medicare, Medicaid, and private insurance at the full retail price for those same drugs. No federal agency reviewed its eligibility. No mechanism exists in the architecture that would prompt that review.The hospital paid the fine. The hospital kept the discount.This week on Edge of the Story, we go to where the most expensive version of the season's question lives. The pharmaceutical reimbursement program known as 340B. A program designed in 1992 to help safety-net hospitals afford drugs for low-income patients. Today, one of the largest government drug programs in the country — with no public mechanism to verify whether the discounted drugs ever reach the patients the program was designed to serve. The American Hospital Association went to federal court in December 2025 and successfully blocked a transparency pilot that would have begun to answer that question. The word the hospital lobby used to block the transparency requirement was patient care.Meanwhile, the President's Most Favored Nation executive order has reached agreements with all 17 major pharmaceutical manufacturers. TrumpRx.gov now offers 750 drugs to consumers. Twelve million unique visitors. $500 million in estimated savings. The word on that program is transparency.Four words now fight over the same pile of money — safety net, national security, patient care, transparency. Four institutions deploying them. And not one of the words describes the patient at the pharmacy counter trying to afford the prescription her doctor just wrote.The Company Moment is the strongest positive story of the season. A radiologist with a math degree from Oxford sent a cold email to twenty-seven billionaires. One of them — Mark Cuban — wrote back. They built a pharmacy that publishes its prices. A generic cancer drug that costs over $9,000 per month through traditional pharmacy channels sells on their site for $14.40. The architecture is not broken. The architecture is a choice. And someone chose to build a different one.SHOW NOTES — S2E4 THE 340B PROGRAM — PUBLIC RESOURCES340B OPAIS — Public Database to Search 340B Hospitalshttps://340bopais.hrsa.govHRSA Office of Pharmacy Affairshttps://www.hrsa.gov/opaCommunity Health Network $345M settlement — DOJhttps://www.justice.gov/usao-sdin/pr/community-health-network-pay-345-million-resolve-false-claims-act-allegations THE 340B TRANSPARENCY LAWSUITAmerican Hospital Association v. HHS — court filingshttps://www.aha.org/press-releasesHRSA proposed 340B pilot transparency programhttps://www.hrsa.gov/opa/program-requirements THE MOST FAVORED NATION EXECUTIVE ORDERExecutive Order on MFN Prescription Drug Pricing, May 12, 2025https://www.whitehouse.gov/presidential-actions/2025/05/delivering-most-favored-nation-prescription-drug-pricing-to-american-patients/Pharmaceutical Tariff Executive Order, April 2, 2026https://www.whitehouse.gov/presidential-actions/2026/04/pharmaceutical-tariffs/Pharmacy Times — Roundup of All 16 MFN Agreementshttps://www.pharmacytimes.com/view/round-up-every-most-favored-nation-agreement-with-the-trump-administrationRegeneron MFN agreement — April 28, 2026 White House fact sheethttps://www.whitehouse.gov/fact-sheets/2026/04/fact-sheet-president-donald-j-trump-announces-deal-with-regeneron-to-bring-most-favored-nation-pricing-to-american-patients/ TRUMPRXTrumpRx.gov — Federal Direct-to-Consumer Pharmacy Sitehttps://www.trumprx.govOz announces 160 more drugs added to TrumpRx — Breitbart, June 2, 2026https://www.breitbart.com/politics/2026/06/02/oz-announces-160-more-drugs-being-added-to-trumprx/ THE COST PLUS DRUGS COMPANY MOMENTThe Mark Cuban Cost Plus Drug Companyhttps://www.costplusdrugs.comHow Cost Plus Drugs Sets Its Prices — Company Disclosurehttps://costplusdrugs.com/how-its-priced/Dr. Alex Oshmyansky founder profilehttps://www.statnews.com/2023/02/14/cost-plus-drug-company-cuban-oshmyansky/Imatinib comparison — Cost Plus Drugs versus retail pharmacy pricinghttps://costplusdrugs.com/medications/imatinib-mesylate-400mg-tablet/ FOR FURTHER READING340B Program History — Congressional Research Servicehttps://crsreports.congress.gov/product/pdf/R/R45709MFN Drug Pricing Executive Order Legal Analysis — Library of Congresshttps://www.congress.gov/crs-product/LSB1131946brooklyn drug pricing research — nonprofit drug pricing analysishttps://www.46brooklyn.comHave you ever been in a room where something shifted—but no one said it out loud?Share your story at www.edgeofthestory.com/heard. If we feature it, we’ll send you an Edge of the Story notebook—because some observations are worth writing down.